drug
abrocitinib
Marketedupdated 4mo agoby $PFE PFIZER INC
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying abrocitinib
- phase3A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
- —Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.
- phase2Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D)
- phase2Study to Investigate the Efficacy of Abrocitinib in Adult Participants With Severe Fatigue From Post COVID Condition/Long COVID
- phase3A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- —A Study to Learn About the Study Medicine (CIBINQO) in People With Atopic Dermatitis.
- phase3Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
- —A Study to Learn About the Study Medicine (Called Cibinqo) in People With Atopic Dermatitis
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jan 14, 2027
143 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (9)
- Jan 14, 2036compositionUS 9035074
- Jan 14, 2036compositionUS 9035074
- Jan 14, 2036compositionUS 9035074
- Feb 19, 2034compositionUS 9545405
- Feb 19, 2034compositionUS 9545405
- Feb 19, 2034compositionUS 9545405
- Feb 19, 2034method-of-use (U-3195)US 9549929
- Feb 19, 2034method-of-use (U-3195)US 9549929
- Feb 19, 2034method-of-use (U-3195)US 9549929
FDA exclusivities (6)
- Jan 14, 2027NCENew Chemical Entity (5y)143d
- Jan 14, 2027NCENew Chemical Entity (5y)143d
- Jan 14, 2027NCENew Chemical Entity (5y)143d
- Feb 9, 2026NPPNew Product (3y)
- Feb 9, 2026NPPNew Product (3y)
- Feb 9, 2026NPPNew Product (3y)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 11m ago
Found something off?
comments(0)
5-min edit window · permanent after that